In Summary
Hims & Hers Health receives a sell signal in its 1st week, but with a signal strength of just 22 out of 100 and trading not recommended by our model. The Health Care sector is in a positive regime, but the stock's technical structure is weak, and our model places this setup among the riskiest in the ranking.
Fresh sell signal
·1st week from start
·US stocks
·T2
IQS Phase
55
ordinary
Signal Strength
22
low · fading
Sizing
MINIMUM
Ranking
#32 / 80
New us stocks
restricted Platinum content